Skip Navigation
Search Menu
Find an Expert

 


Anika Adero Hardie Alvanzo, M.D., M.S.

Photo of Dr. Anika Adero Hardie Alvanzo, M.D., M.S.

Medical Director, Substance Use Disorders Consultation Service

Assistant Professor of Medicine

Female

Expertise: Addiction Medicine, Internal Medicine

Research Interests: Screening and brief interventions for at-risk substance use; Race/ethnicity and sex differences in substance use disorders; Substance use disorders and posttraumatic stress with emphasis on relationship between physical, sexual, and/or emotional abuse and substance use in women ...read more

Locations

The Johns Hopkins Hospital

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map
Phone: 410-502-2048
Fax: 410-502-6952

Background

Dr. Anika Alvanzo is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include addiction medicine and internal medicine. Dr. Alvanzo serves as the medical director of the Substance Use Disorders Consultation Service.

Dr. Alvanzo received her M.D. from the George Washington University School of Medicine. She completed her residency and a fellowship in internal medicine at Virginia Commonwealth University Health System.

Her research interests include screening and brief interventions for at-risk substance use, and race/ethnicity and sex differences in substance use disorders.

...read more

Titles

  • Medical Director, Substance Use Disorders Consultation Service
  • Assistant Professor of Medicine

Departments / Divisions

Education

Degrees

  • MD, George Washington University School of Medicine (1999)

Residencies

  • Virginia Commonwealth University Health System / Internal Medicine (2002)

Fellowships

  • Virginia Commonwealth University Health System / Internal Medicine (2004)

Board Certifications

  • American Board of Internal Medicine / Internal Medicine (2002)

Research & Publications

Lab Website: Anika Alvanzo Lab

Selected Publications

View all on Pubmed

Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, Miele GM, Kunkel LE, Norton M, Stitzer ML. "The use of technology in participant tracking and study retention: lessons learned from a clinical trials network study." Subst Abus. 2015 Feb 11:0. [Epub ahead of print]

Reuben DB, Alvanzo AA, Ashikaga T, Bogat GA, Callahan CM, Ruffing V, Steffens DC. "National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain." Ann Intern Med. 2015 Feb 17;162(4):295-300. doi: 10.7326/M14-2775.

Keyser-Marcus L, Alvanzo A, Rieckmann T, Thacker L, Sepulveda A, Forcehimes A, Islam LZ, Leisey M, Stitzer M, Svikis DS. "Trauma, gender, and mental health symptoms in individuals with substance use disorders." J Interpers Violence. 2015 Jan;30(1):3-24. doi: 10.1177/0886260514532523. Epub 2014 May 8.

Alvanzo AA, Storr CL, Mojtabai R, Green KM, Pacek LR, La Flair LN, Cullen BA, Crum RM. "Gender and race/ethnicity differences for initiation of alcohol-related service use among persons with alcohol dependence." Drug Alcohol Depend. 2014 Jul 1;140:48-55. doi: 10.1016/j.drugalcdep.2014.03.010. Epub 2014 Mar 20.

Pacek LR, Storr CL, Mojtabai R, Green KM, La Flair LN, Alvanzo AA, Cullen BA, Crum RM, "Comorbid alcohol dependence and anxiety disorders: a national survey." J Dual Diagn. 2013;9(4). doi: 10.1080/15504263.2013.835164.

Pacek LR, Storr CL, Mojtabai R, Green KM, La Flair LN, Alvanzo AA, Cullen BA, Crum RM. Comorbid Alcohol Dependence and Anxiety Disorders: A National Survey. J Dual Diagn. 2013;9(4). doi: 10.1080/15504263.2013.835164. PMID: 24223532

Cullen BA, La Flair LN, Storr CL, Green KM, Alvanzo AA, Mojtabai R, Pacek LR, Crum RM. Association of comorbid generalized anxiety disorder and alcohol use disorder symptoms with health-related quality of life: results from the national epidemiological survey on alcohol and related conditions. J Addict Med. 2013 Nov-Dec;7(6):394-400. doi: 10.1097/ADM.0b013e31829faa1c. PMID: 24145158

La Flair LN, Reboussin BA, Storr CL, Letourneau E, Green KM, Mojtabai R, Pacek LR, Alvanzo AA, Cullen B, Crum RM. Childhood abuse and neglect and transitions in stages of alcohol involvement among women: a latent transition analysis approach. Drug Alcohol Depend. 2013 Oct 1;132(3):491-8. doi: 10.1016/j.drugalcdep.2013.03.012. Epub 2013 Apr 29. PMID: 23639389

Crum RM, Mojtabai R, Lazareck S, Bolton JM, Robinson J, Sareen J, Green KM, Stuart EA, La Flair L, Alvanzo AA, Storr CL. A prospective assessment of reports of drinking to self-medicate mood symptoms with the incidence and persistence of alcohol dependence. JAMA Psychiatry. 2013 Jul;70(7):718-26. doi: 10.1001/jamapsychiatry.2013.1098. PMID: 23636710

Crum RM, La Flair L, Storr CL, Green KM, Stuart EA, Alvanzo AA, Lazareck S, Bolton JM, Robinson J, Sareen J, Mojtabai R. Reports of drinking to self-medicate anxiety symptoms: longitudinal assessment for subgroups of individuals with alcohol dependence. Depress Anxiety. 2013 Feb;30(2):174-83. doi: 10.1002/da.22024. Epub 2012 Dec 20. PMID: 23280888

Schwartz RP, Stitzer ML, Feaster DJ, Korthuis PT, Alvanzo AA, Winhusen TM, Donnard L, Snead N, Metsch LR. HIV rapid testing in drug treatment: comparison across treatment modalities. J Subst Abuse Treat. 2013 Apr;44(4):369-74. doi: 10.1016/j.jsat.2012.08.219. Epub 2012 Sep 27. PMID: 23021496

Neufeld KJ, Alvanzo A, King VL, Feldman L, Hsu JH, Rastegar DA, Colbert JM, MacKinnon DF. A collaborative approach to teaching medical students how to screen, intervene, and treat substance use disorders. Subst Abus. 2012;33(3):286-91. doi: 10.1080/08897077.2011.640090. PMID: 22738007

La Flair LN, Bradshaw CP, Storr CL, Green KM, Alvanzo AA, Crum RM. Intimate partner violence and patterns of alcohol abuse and dependence criteria among women: a latent class analysis. J Stud Alcohol Drugs. 2012 May;73(3):351-60. PMID: 22456240

Gruber VA, Rainey PM, Moody DE, Morse GD, Ma Q, Prathikanti S, Pade PA, Alvanzo AA, McCance-Katz EF. Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir. Clin Infect Dis. 2012 Feb 1;54(3):414-23. doi: 10.1093/cid/cir799. Epub 2011 Nov 18. PMID: 22100576

Alvanzo AA, Storr CL, La Flair L, Green KM, Wagner FA, Crum RM. Race/ethnicity and sex differences in progression from drinking initiation to the development of alcohol dependence. Drug Alcohol Depend. 2011 Nov 1;118(2-3):375-82. doi: 10.1016/j.drugalcdep.2011.04.024. Epub 2011 Jun 11. PMID: 21652154

Is this you? Edit Profile